News
Detecting CAR T cells to improve immunotherapy
Over the past five years, CAR T-cell therapy has given some cancer patients hope for remission. This form of immunotherapy adds a gene — called a chimeric antigen receptor, or CAR — to a patient’s T cells, which helps these immune cells find and attack cancers. To...
$10 million gift accelerates research to improve cancer therapies, extend benefits to more patients
Researchers at the University of Chicago Medicine will come together to develop personalized therapies for hard-to-treat cancers, thanks to a $10 million gift from the Jonas family. The gift establishes the David and Etta Jonas Center for Cellular Therapy at UChicago...
Stem cell transplant team looks inward to improve survival rates for patients
When a car stops running, the cause usually turns out to be a broken part that needs to be replaced. Similarly, in the bone marrow of patients with blood diseases, the stem cells responsible for creating blood cells are not working as they should. Through a procedure...